The global hepatitis diagnostic test market is poised for significant growth, with market value projected to increase from USD 3621.5 million in 2024 to USD 6118.4 million by 2033, reflecting a steady ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Phosphoproteomics unveils the mode of action of clinical ATR inhibitors and explains their synergy with Gemcitabine in ...

Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway. However, whether Wnt ligands induce FZD endocytosis and degradation remains elusive. The transmembrane E3 ubiquitin ...

In this valuable study, Roiuk et al employed a combination of ribosome profiling and reporter assays to provide convincing evidence that eIF2A is not involved in translational regulation in cultured ...

The global LAMP market is projected to grow from USD 110.6 million in 2024 to USD 178.4 million by 2034, at a CAGR of 4.9%.

The COVID-19 outbreak in 2019 triggered measures to raise public awareness regarding pandemics and also led to fast-tracked ...

Discover effective methods to determine the gravimetric sample composition of mixtures with unknown constituents, ensuring reliable analytical results.

NYSE:QGEN) QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples ...

Perhaps this model holds the most promise for standardizing the molecular tests since the commercial assays provide standardized methods and quality-controlled reagents. Commercial Molecular Tests ...

Michael Scholle Appointed CEO of Tango Biosciences, the premier research partner for custom affinity reagents by phage ...

Scholle brings more than 25 years of experience in building biotech companies with expertise in commercializing technology platforms, high-throughput drug discovery, molecular biology, phage ...